HK1088327A1 - Thiadiazine derivatives and use thereof as positive ampa receptor modulator - Google Patents

Thiadiazine derivatives and use thereof as positive ampa receptor modulator

Info

Publication number
HK1088327A1
HK1088327A1 HK06108870A HK06108870A HK1088327A1 HK 1088327 A1 HK1088327 A1 HK 1088327A1 HK 06108870 A HK06108870 A HK 06108870A HK 06108870 A HK06108870 A HK 06108870A HK 1088327 A1 HK1088327 A1 HK 1088327A1
Authority
HK
Hong Kong
Prior art keywords
receptor modulator
ampa receptor
thiadiazine derivatives
positive ampa
positive
Prior art date
Application number
HK06108870A
Other languages
English (en)
Inventor
Graindorge Emmanuel
Francotte Pierre
Boverie Stephane
De Tullio Pascal
Pirotte Bernard
Lestage Pierre
Danober Laurence
Renard Pierre
Caignard Daniel-Henri
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1088327A1 publication Critical patent/HK1088327A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK06108870A 2003-05-05 2006-08-10 Thiadiazine derivatives and use thereof as positive ampa receptor modulator HK1088327A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0305448A FR2854634B1 (fr) 2003-05-05 2003-05-05 Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2004/001070 WO2004099217A1 (fr) 2003-05-05 2004-05-04 Derives de thiadiazine et leur utilisation comme modulateurs positifs des recepteurs ampa

Publications (1)

Publication Number Publication Date
HK1088327A1 true HK1088327A1 (en) 2006-11-03

Family

ID=33306157

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06108870A HK1088327A1 (en) 2003-05-05 2006-08-10 Thiadiazine derivatives and use thereof as positive ampa receptor modulator

Country Status (21)

Country Link
US (1) US7476668B2 (fr)
EP (1) EP1620441A1 (fr)
JP (1) JP4461139B2 (fr)
KR (1) KR100741235B1 (fr)
CN (1) CN100363368C (fr)
AR (1) AR044245A1 (fr)
AU (1) AU2004236005B2 (fr)
BR (1) BRPI0410002A (fr)
CA (1) CA2524377C (fr)
EA (1) EA009240B1 (fr)
FR (1) FR2854634B1 (fr)
GE (1) GEP20084318B (fr)
HK (1) HK1088327A1 (fr)
MA (1) MA27732A1 (fr)
MX (1) MXPA05011823A (fr)
MY (1) MY136694A (fr)
NO (1) NO20055695L (fr)
NZ (1) NZ543214A (fr)
UA (1) UA80046C2 (fr)
WO (1) WO2004099217A1 (fr)
ZA (1) ZA200508660B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2539969T3 (es) 2004-08-25 2015-07-07 Essentialis, Inc. Formulaciones farmacéuticas de activadores del canal de potasio de ATP y usos de las mismas
ATE529113T1 (de) 2006-01-05 2011-11-15 Essentialis Inc Salze von kalium-atp-kanal-öffnern und ihre verwendungen
WO2010054336A2 (fr) * 2008-11-10 2010-05-14 The Regents Of The University Of California Utilisations thérapeutiques de modulateurs du récepteur ampa pour le traitement d'un dysfonctionnement moteur
PT2603513T (pt) 2010-08-10 2020-06-08 Takeda Pharmaceuticals Co Composto heterocíclico e sua utilização como modulador alostérico positivo do recetor de ampa
JP5901365B2 (ja) * 2012-03-12 2016-04-06 株式会社トクヤマ イミダート化合物の製造方法
AU2014277952A1 (en) 2013-06-13 2016-01-28 Veroscience Llc Compositions and methods for treating metabolic disorders
US10335503B2 (en) 2015-07-06 2019-07-02 Public University Corporation Yokohama City University Compound that specifically binds to AMPA receptor
JP6241974B1 (ja) 2017-01-11 2017-12-06 公立大学法人横浜市立大学 霊長類生体の脳内ａｍｐａ受容体のイメージング方法、プログラム、及びスクリーニング方法
US10680583B1 (en) * 2019-02-26 2020-06-09 Xilinx, Inc. Control circuit for and method of controlling an operation of an integrated circuit device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3733409A (en) * 1969-05-20 1973-05-15 Schering Corp Method of treating hypertension using thieno (1,2,4) thiadiazines
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
BR9810592A (pt) * 1997-07-16 2000-09-12 Novo Nordisk As Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto
IL137720A0 (en) * 1998-02-18 2001-10-31 Neurosearch As Compounds and their use as positive ampa receptor modulators
FR2801587B1 (fr) * 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
FR2854634B1 (fr) 2005-07-08
MY136694A (en) 2008-11-28
WO2004099217A1 (fr) 2004-11-18
JP2006525292A (ja) 2006-11-09
AR044245A1 (es) 2005-09-07
CN100363368C (zh) 2008-01-23
EA200501696A1 (ru) 2006-06-30
NZ543214A (en) 2009-02-28
FR2854634A1 (fr) 2004-11-12
BRPI0410002A (pt) 2006-04-25
GEP20084318B (en) 2008-03-10
AU2004236005A1 (en) 2004-11-18
US20070004709A1 (en) 2007-01-04
JP4461139B2 (ja) 2010-05-12
ZA200508660B (en) 2007-01-31
US7476668B2 (en) 2009-01-13
EA009240B1 (ru) 2007-12-28
UA80046C2 (en) 2007-08-10
NO20055695L (no) 2005-12-01
CN1798750A (zh) 2006-07-05
AU2004236005B2 (en) 2010-01-21
CA2524377C (fr) 2010-08-24
CA2524377A1 (fr) 2004-11-18
MXPA05011823A (es) 2006-05-25
KR20060006830A (ko) 2006-01-19
EP1620441A1 (fr) 2006-02-01
KR100741235B1 (ko) 2007-07-19
MA27732A1 (fr) 2006-01-02

Similar Documents

Publication Publication Date Title
HK1080846A1 (en) Benzoxazine derivatives as 5-ht6 modulators and uses thereof
HK1088327A1 (en) Thiadiazine derivatives and use thereof as positive ampa receptor modulator
IL166552A0 (en) Pyrimidine derivatives and their use as cb2 modulators
AU157771S (en) Orthotic
PL372123A1 (en) Thiazole derivatives
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
GB0201149D0 (en) Prosthesis
GB0219280D0 (en) Prosthesis
AP2004003110A0 (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
EP1530449A4 (fr) Cornee artificielle
IL165924A0 (en) Indolin phenylsulfonamide derivatives
AU156929S (en) Orthotic
AU2003299935A8 (en) Stomach prosthesis
IL166121A0 (en) Indole-3-sulphur derivatives
PL3002283T3 (pl) Pochodne tiazolu
PL376475A1 (en) N-substituted-2-oxodihydropyridine derivatives
IL172894A0 (en) Indol-6-sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
IL172891A0 (en) Indol-5-yl-sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
GB0315870D0 (en) Heterocyclic derivatives
AU2003266119A8 (en) Artificial joint
IL172750A0 (en) Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
HRP20031007A2 (en) Benzoxazepine derivatives and their use as ampa receptor stimulators
AU2003294938A8 (en) Epothilone derivatives
EP1531854A4 (fr) Derives de nocathiacine o-derivatises

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120504